<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00788723</url>
  </required_header>
  <id_info>
    <org_study_id>HNRC-AAU-08-1</org_study_id>
    <nct_id>NCT00788723</nct_id>
  </id_info>
  <brief_title>Cortical Excitability in Patients With Severe Brain Injury</brief_title>
  <official_title>Cortical Excitability in Patients With Severe Brain Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the cortical excitability in the severe brain injured
      patients. We hypothesize that:

        1. There is a continuous decrease in intracortical inhibition from healthy subjects to
           awake patients with severe brain injury, and to patients with impaired consciousness.

        2. Decreased intracortical inhibition correlate with the degree of impairment assessed with
           the clinical scores in patients with severe brain injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: Prospective controlled non-randomized study. Materials and methods: 30 patients with
      severe brain injury and 15 healthy volunteers will be included in this study.

      The study design is illustrated below:

        1. Clinical assessment (Rancho Los Amigos Scale, Functional Independence Measure, Early
           Functional Abilities).

        2. Somatosensory Evoked Potentials.

        3. Transcranial Magnetic Stimulation: single and paired stimulation protocols.

      Statistical evaluation: All collected data will be tested with reference to normal
      distribution. If the data is not distributed normally, then we will use either a logarithmic
      transformation before we use parametric statistics, or we will use non-parametric statistics
      for further calculations.Further analysis of the data will be done with the help of variance
      analysis with an inter-individually factor as a group (awake patients vs patients with
      disorders of consciousness vs control persons) and intra-individually factors as 1)
      interstimulus intervals for transcranial magnetic stimulation and clinical scores (RLAS vs
      FIM vs EFA).

      Significance level is set to 0.05 for all effect parameters.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2008</start_date>
  <completion_date type="Anticipated">May 2009</completion_date>
  <primary_completion_date type="Anticipated">March 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Short Afferent Inhibition</measure>
    <time_frame>Within one week after clinical assessment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Short Intracortical Inhibition</measure>
    <time_frame>Within one week after clinical assessment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intracortical Facilitation</measure>
    <time_frame>Within one week after clinical assessment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor threshold</measure>
    <time_frame>Within one week after clinical assessment</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Severe Traumatic Brain Injury</condition>
  <condition>Subarachnoid Hemorrhage</condition>
  <condition>Anoxic Brain Injury</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with severe brain injury, awake, but have cognitive problems</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with severe brain injury and disorders of consciousness ( in minimally conscious or in vegetative state)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation</intervention_name>
    <description>Transcranial magnetic stimulation (TMS) using paired-pulse technique at different interstimulus intervals (ISIs) allows the study of the excitatory and inhibitory system of human motor cortex non-invasively. Motor evoked potentials (MEP) will be recorded, and stored on a VikingSelect (Viasys Healthcare, USA). Two magnetic stimulators (Magstim 200, The Magstim Company Ltd, U.K.) connected through a Bistim and a Magstim figure-of-eight coil will be used for TMS.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <other_name>Paired-pulse transcanial magnetic stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. severe brain injury (Glasgow Coma Scale score (GCS) less than 8 on admission to the
             acute hospital);

          2. stable vital functions;

          3. age over 18 years old;

          4. informed content from patient/relatives/legal guardian.

        Exclusion Criteria:

          1. other neurological diseases than brain injury;

          2. pregnancy;

          3. TMS contraindications (epilepsy, metallic implantants: pacemaker or medicine pump,
             ferromagnetic or electronically operated stapedial implants, haemostatic clips,
             metallic splinters in the orbit).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Natallia Lapitskaya, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hammel Neurorehabilitation and Research Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Natallia Lapitskaya, MD</last_name>
    <phone>004587623573</phone>
    <email>neunla@sc.aaa.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lena Bjorn, secretary</last_name>
    <phone>0045 8762 3562</phone>
    <email>neuleb@sc.aaa.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hammel Neurorehabilitation and Research Centre</name>
      <address>
        <city>Hammel</city>
        <zip>8450</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natallia Lapitskaya, MD</last_name>
      <phone>004587623573</phone>
      <email>neunla@sc.aaa.dk</email>
    </contact>
    <contact_backup>
      <last_name>Lena Bjorn, secretary</last_name>
      <phone>004587623562</phone>
      <email>neuleb@sc.aaa.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Natallia Lapitskaya, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sofie Moerk, med.stud.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2008</study_first_submitted>
  <study_first_submitted_qc>November 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2008</study_first_posted>
  <last_update_submitted>November 10, 2008</last_update_submitted>
  <last_update_submitted_qc>November 10, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2008</last_update_posted>
  <responsible_party>
    <name_title>Natallia Lapitskaya, MD</name_title>
    <organization>Hammel Neurorehabilitation and Research Centre</organization>
  </responsible_party>
  <keyword>Severe Brain Injury</keyword>
  <keyword>Excitability</keyword>
  <keyword>Transcranial Magnetic Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

